Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsIDE

IDE

Biotechnology

GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of GalleriⓇ Multi-Cancer Early Detection (MCED) Test Among The Medicare Population

News Desk -
Prospective, Multi-Center Study Will Assess the Clinical Impact of Galleri® in addition to Currently Recommended Cancer Screenings in the Medicare Population GRAIL, LLC, a healthcare company...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us